Annals of Hematology

, Volume 72, Issue 5, pp 333–335 | Cite as

Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy

  • R. Rho
  • T. Laddis
  • C. McQuain
  • J. Selves
  • B. Woda
  • H. Knecht
Case Report

Abstract

A 74-year-old woman developed angioimmunoblastic lymphadenopathy (AILD) with involvement of intra-abdominal and retroperitoneal lymph nodes. Southern blot analysis showed germline configuration of the JH genes and an oligoclonal pattern of the TcRβ genes. The immunoblasts were of B-cell phenotype and often expressed the CD30 antigen and the latent membrane protein 1 (LMP1) oncogene. Six nonsilent point mutations were identified near the 3′ end of the LMP1 gene, leading to a cluster of six amino acid changes within a protein domain needed for maximal NF-κB stimulation. After a clinical remission of 8 months the patient relapsed with generalized lymphadenopathy and died secondary to tuberculosis. The oligoclonal rearrangements of the TcRβ genes may reflect an unsuccessful cellular immune response to Mycobacterium tuberculosis or an HLA-restricted T-cell response to B-immunoblasts expressing mutated viral antigens. A positive percutaneous tuberculin test observed 6 months prior to the onset of AILD is in favor of the first possibility.

Key words

Angioimmunoblastic lymphadenopathy Miliary tuberculosis Epstein-Barr virus Latent membrane protein 1 Point mutations 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brousset P, Schlaifer D, Meggetto F, Bachmann E, Rothenberger S, Delsol G, Knecht H (1994) Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin’s disease. Blood 84: 2447–2451PubMedGoogle Scholar
  2. 2.
    Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42: 329–338PubMedCrossRefGoogle Scholar
  3. 3.
    Frizzera G, Moran EM, Rappaport H (1974) Angio-immuno-blastic lymphadenopathy with dysproteinanemia. Lancet 1: 1070–1073PubMedCrossRefGoogle Scholar
  4. 4.
    Hatty S, Mufti GJ, Hamblin TJ (1985) Angio-immunoblastic lymphadenopathy with hypogammaglobulinaemia complicated by miliary tuberculosis. Acta Haematol 73: 37–39PubMedCrossRefGoogle Scholar
  5. 5.
    Henderson SA, Huen D, Rowe M (1994) Epstein-Barr virustransforming proteins. Virology 5: 391–399Google Scholar
  6. 6.
    Kim JH, Langsten AA, Gallis HA (1990) Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis 12: 583–590PubMedGoogle Scholar
  7. 7.
    Knecht H (1989) Angioimmunoblastic lymphadenopathy: ten years’experience and state of current knowledge. Semin Hematol 26: 208–215PubMedGoogle Scholar
  8. 8.
    Knecht H, Sahli R, Shaw P, Meyer C, Bachmann E, Odermatt BF (1990) Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy. Br J Haematol 75: 610–614PubMedCrossRefGoogle Scholar
  9. 9.
    Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF (1995) Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10: 523–528PubMedGoogle Scholar
  10. 10.
    Lukes RJ, Tindle B (1975) Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292: 1–8PubMedCrossRefGoogle Scholar
  11. 11.
    Maartens G, Willcox PA, Benatar SR (1990) Miliary tuberculosis: rapid diagnosis, hématologic abnormalities, and outcome in 109 treated adults. Am J Med 89: 291–296PubMedCrossRefGoogle Scholar
  12. 12.
    Mitchell T, Sugden B (1995) Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol 69: 2968–2976PubMedGoogle Scholar
  13. 13.
    Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin’s disease. Lancet 1: 320–322CrossRefGoogle Scholar
  14. 14.
    Sadovsky R, Zazakos C (1977) Angioimmunoblastic lymphadenopathy: common symptoms, uncommon diagnosis.Postgrad Med 62: 213–216PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • R. Rho
    • 1
  • T. Laddis
    • 1
  • C. McQuain
    • 1
  • J. Selves
    • 2
  • B. Woda
    • 3
  • H. Knecht
    • 1
  1. 1.Hematology/Oncology Division, Department of Medicine and LINK Laboratories at the Cancer CenterUniversity of Massachusetts Medical CenterWorcesterUSA
  2. 2.Laboratoire d’Anatomie PathologiqueUniversity Hospital PurpanToulouseFrance
  3. 3.Department of PathologyUniversity of Massachusetts Medical CenterWorcesterUSA

Personalised recommendations